OLA
Oliver Luxxe Assets’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,820
| Closed | -$218K | – | 131 |
|
|
2020
Q1 | $218K | Buy |
5,820
+231
| +4% | +$8.65K | 0.14% | 109 |
|
|
2019
Q4 | $255K | Sell |
5,589
-1,309
| -19% | -$59.7K | 0.13% | 111 |
|
|
2019
Q3 | $244K | Buy |
6,898
+460
| +7% | +$16.3K | 0.14% | 106 |
|
|
2019
Q2 | $252K | Buy |
6,438
+19
| +0.3% | +$744 | 0.14% | 108 |
|
|
2019
Q1 | $267K | Buy |
6,419
+306
| +5% | +$12.7K | 0.15% | 102 |
|
|
2018
Q4 | $224K | Buy |
6,113
+886
| +17% | +$32.5K | 0.15% | 94 |
|
|
2018
Q3 | $240K | Buy |
+5,227
| New | +$240K | 0.14% | 93 |
|
|
2018
Q1 | – | Sell |
-23,935
| Closed | -$1.04M | – | 103 |
|
|
2017
Q4 | $1.04M | Buy |
23,935
+1,280
| +6% | +$55.7K | 0.63% | 46 |
|
|
2017
Q3 | $964K | Buy |
+22,655
| New | +$964K | 0.61% | 47 |
|